market share
Humira sales decline as biosimilars gain traction, but physicians remain wary of switching patients
Anika Sharma
In the race to capture a share of the $20 billion annual revenue generated by AbbVie’s blockbuster biologic, Humira biosimilars ...
Pfizerâs tafamidis faces competition from Alnylam and BridgeBio in rare disease market
Anika Sharma
Alnylam and BridgeBio are poised to enter the highly lucrative transthyretin amyloidosis cardiomyopathy (ATTR-CM) market with the backing of an ...
